Showing results (881-890 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|January 11, 2019
Cost-effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patientsXiaoXia Wei, JiaQin Cai, Hong Sun, et al.Pharmacogenomics|January 11, 2019
Genetic variation of kinases and activation of nucleotide analog reverse transcriptase inhibitor tenofovirAllyson N Hamlin, Joseph Tillotson, Namandjé N BumpusPharmacogenomics|December 7, 2018
Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohortKyle Melin, Jee-Young Moon, Qibin Qi, et al.Pharmacogenomics|November 23, 2019
The effects of rosiglitazone on the neonatal rat cardiomyocyte transcriptome: a temporal analysisWillian Abraham da Silveira, Esteban Vazquez-Hidalgo, Elesha Bartolotta, et al.Pharmacogenomics|November 27, 2019
CYP2D6*10 pharmacogenetic-guided SERM could be a cost-effective strategy in Chinese patients with hormone receptor-positive breast cancerXiaoxia Wei, Jiaqin Cai, Jie Zhuang, et al.Pharmacogenomics|November 28, 2017
Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorderStefano Fortinguerra, Alessandro Buriani, Vincenzo Sorrenti, et al.Pharmacogenomics|December 2, 2017
Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasisMaría C Ovejero-Benito, Rocío Prieto-Pérez, Mar Llamas-Velasco, et al.Pharmacogenomics|December 6, 2017
Precision medicine for HIV: where are we?Jessica Cusato, Sarah Allegra, Amedeo De Nicolò, et al.Pharmacogenomics|December 13, 2019
Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanomaAndrew Kl Goey, Mirjam de With, Bram C Agema, et al.Pharmacogenomics|February 22, 2018
Genetic variations in genes of the stress response pathway are associated with prolonged abstinence from heroinOrna Levran, Einat Peles, Matthew Randesi, et al.Pageof 276